| |
|
|
|
Latest Local News
The most recent Business Journal articles featured in the Latest Local News section of the Web site.
Stemgent Makes Investment in Scottish Biotech
Stemgent Inc., a provider of biological materials for stem cell research with offices in Cambridge, Mass. and San Diego, said March 8 it will invest $4.5 million during the next three years in a Scottish biotech startup.
West Wireless Health Institute Names CEO
San Diego’s West Wireless Health Institute, formed a year ago to push wireless solutions for the health care industry, has appointed a former Johnson & Johnson executive to serve as its first chief executive officer.
Survey Pegs Second-Quarter Hiring as Modest
San Diego area employers said they expect to hire at a modest pace during the second quarter, according to the Manpower Employment Survey released March 9.
Nine Tenants Flock to Carlsbad Retail Center
Bressi Village Shopping Center, at 2629-2687 Gateway Road in Carlsbad, gained nine new tenants that signed leases totaling $6 million during 2009, operators said in a statement.
Emerging from Stealth Mode, Afraxis Makes Hires
Afraxis, a San Diego-based biotech testing a treatment for Fragile X syndrome, said March 8 it has appointed a chief scientific officer and vice president.
Class Action Attorney Finishes Prison Sentence
Bill Lerach, the San Diego class action attorney sentenced to two years in federal prison in 2008 after pleading guilty to a single felony of criminal conspiracy and obstructing justice, was officially released from custody March 8, according to the Federal Bureau of Prisons.
Barney & Barney Associates Rise to the Top
A specialty business publication has singled out two insurance brokers from Barney & Barney LLC as tops in their field, the insurance firm said March 4.
Leap Wireless Reduces Staff
Leap Wireless International Inc., the San Diego parent firm of flat-rate cell phone carrier Cricket Communications, recently cut 180 full-time positions from its 4,200-person work force.
Isis Receives Milestone Payment
A regulatory acceptance has triggered a $6 million milestone payment to Isis Pharmaceuticals Inc. from partner Bristol-Myers Squibb Co. as part of the drug makers’ collaboration on a cholesterol-lowering treatment.
Novalar Goes After European Customers
San Diego-based Novalar Pharmaceuticals Inc. has signed an exclusive deal with pharmaceutical giant Sanofi-Aventis to market its dental anesthetic reversal agent in Germany.
|
|
|
|
| |
